Search

Author/Creator Rosenberg, Jonathan E.

1. A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor‐targeted therapies. Issue 15 (19th May 2016)

Authors:
McKay, Rana R.; De Velasco, Guillermo; Werner, Lillian; Bellmunt, Joaquim; Harshman, Lauren; Sweeney, Christopher; Rosenberg, Jonathan E.; Hirsch, Michelle; Signoretti, Sabina; Van Allen, Eliezer M.; Walsh, Meghara; Vaishampayan, Ulka; McDermott, David F.; Choueiri, Toni K.
Journal:
Cancer
Issue:
Volume 122:Issue 15(2016)
Page Start:
2389
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 2 trial of buparlisib in patients with platinum‐resistant metastatic urothelial carcinoma. Issue 20 (7th August 2020)

Authors:
McPherson, Victor; Reardon, Brendan; Bhayankara, Aravind; Scott, Sasinya N.; Boyd, Mariel E.; Garcia‐Grossman, Ilana R.; Regazzi, Ashley M.; McCoy, Asia S.; Kim, Philip H.; Al‐Ahmadie, Hikmat; Ostrovnaya, Irina; Roth, Andrew J.; Farooki, Azeez; Berger, Michael F.; Rosenberg, Jonathan E.; Solit, D...
Journal:
Cancer
Issue:
Volume 126:Issue 20(2020)
Page Start:
4532
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A phase II trial of durvalumab and tremelimumab in metastatic, non‐urothelial carcinoma of the urinary tract. (31st December 2020)

Authors:
Sarfaty, Michal; Whiting, Karissa; Teo, Min Yuen; Lee, Chung‐Han; Peters, Vanessa; Durocher, Jennifer; Regazzi, Ashley M.; McCoy, Asia S.; Hettich, Grace; Jungbluth, Achim A.; Al‐Ahmadie, Hikmat; Ostrovnaya, Irina; Chaim, Joshua; Bajorin, Dean F.; Rosenberg, Jonathan E.; Iyer, Gopa; Funt, Samuel A.
Journal:
Cancer medicine
Issue:
Volume 10:Number 3(2021)
Page Start:
1074
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle‐invasive bladder cancer. Issue 15 (14th April 2015)

Authors:
Galsky, Matthew D.; Pal, Sumanta K.; Chowdhury, Simon; Harshman, Lauren C.; Crabb, Simon J.; Wong, Yu‐Ning; Yu, Evan Y.; Powles, Thomas; Moshier, Erin L.; Ladoire, Sylvain; Hussain, Syed A.; Agarwal, Neeraj; Vaishampayan, Ulka N.; Recine, Federica; Berthold, Dominik; Necchi, Andrea; Theodore, Chr...
Journal:
Cancer
Issue:
Volume 121:Issue 15(2015)
Page Start:
2586
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer. Issue 15 (22nd April 2015)

Authors:
McKay, Rana R.; Gray, Kathryn P.; Hayes, Julia H.; Bubley, Glenn J.; Rosenberg, Jonathan E.; Hussain, Arif; Kantoff, Philip W.; Taplin, Mary‐Ellen
Journal:
Cancer
Issue:
Volume 121:Issue 15(2015)
Page Start:
2603
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU). Issue 1 (1st January 2023)

Authors:
Rosenberg, Jonathan E.; Park, Se Hoon; Kozlov, Vadim; Dao, Tu V.; Castellano, Daniel; Li, Jian-Ri; Mukherjee, Som D.; Howells, Kathryn; Dry, Hannah; Lanasa, Mark C.; Stewart, Ross; Bajorin, Dean F.
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 1(2023)
Page Start:
43
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer. Issue 1 (1st January 2023)

Authors:
Hoimes, Christopher J.; Flaig, Thomas W.; Milowsky, Matthew I.; Friedlander, Terence W.; Bilen, Mehmet Asim; Gupta, Shilpa; Srinivas, Sandy; Merchan, Jaime R.; McKay, Rana R.; Petrylak, Daniel P.; Sasse, Carolyn; Moreno, Blanca Homet; Yu, Yao; Carret, Anne-Sophie; Rosenberg, Jonathan E.
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 1(2023)
Page Start:
22
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma. Issue 1 (28th September 2017)

Authors:
Kamat, Ashish M.; Bellmunt, Joaquim; Galsky, Matthew D.; Konety, Badrinath R.; Lamm, Donald L.; Langham, David; Lee, Cheryl T.; Milowsky, Matthew I.; O'Donnell, Michael A.; O'Donnell, Peter H.; Petrylak, Daniel P.; Sharma, Padmanee; Skinner, Eila C.; Sonpavde, Guru; Taylor, John A.; Abraham, Pras...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 5:Issue 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗